Translational research in the muscular dystrophies is expanding, as academic and industry partnerships yield new potential treatments that are currently being assessed in clinics around the world.
The Muscle Cell Biology, Pathophysiology, and Therapeutics program is capitalizing on the momentum that arose from this explosion of translational research.
